AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON OCTOBER 28, 1999
REGISTRATION NO. 333-44881
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
-------------
POST-EFFECTIVE AMENDMENT NO. 1
TO
FORM S-3
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
TRIANGLE PHARMACEUTICALS, INC.
(Exact name of Registrant as Specified in Its Charter)
DELAWARE 56-1930728
(State or Other Jurisdiction (I.R.S. Employer
of Incorporation or Organization) Identification No.)
4 UNIVERSITY PLACE
4611 UNIVERSITY DRIVE
DURHAM, NORTH CAROLINA, 27707
(919) 493-5980
(Address, Including Zip Code and Telephone, Including Area Code,
of Registrant's Principal Executive Offices)
DAVID W. BARRY, M.D.
CHAIRMAN AND CHIEF EXECUTIVE OFFICER
TRIANGLE PHARMACEUTICALS, INC.
4 UNIVERSITY PLACE, 4611 UNIVERSITY DRIVE
DURHAM, NORTH CAROLINA, 27707, (919) 493-5980
(Name, Address, Including Zip Code and Telephone Number,
Including Area Code, of Agent for Service)
Copies To:
ELLEN B. CORENSWET, ESQ.
LUCI STALLER ALTMAN, ESQ.
BROBECK, PHLEGER & HARRISON LLP
1633 BROADWAY, 47TH FLOOR
NEW YORK, NEW YORK 10019
(212) 581-1600
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
<PAGE>
DEREGISTRATION OF SHARES
Triangle amends this Registration Statement on Form S-3 (Reg. No. 333-44881) to
deregister and remove from registration 2,789,500 shares of Triangle's Common
Stock remaining unsold at the conclusion of the offering described in the
registration statement. The shares were being offered by certain selling
stockholders of Triangle.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the Registrant
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-3 and has duly caused this Registration
Statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of Durham, State of North Carolina, on the 28th day of
October, 1999.
TRIANGLE PHARMACEUTICALS, INC.
By: /s/ DAVID W. BARRY
-----------------------------------------
David W. Barry
CHAIRMAN AND CHIEF EXECUTIVE OFFICER
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons in the
capacities and on the dates indicated:
SIGNATURE TITLE
- --------------------------- --------------------------
Chairman of the Board and
/s/ DAVID W. BARRY Chief Executive Officer
- --------------------------- (Principal Executive Officer) October 28, 1999
David W. Barry
Acting Chief Financial
/s/ THOMAS R. STAAB II Officer and Treasurer
- --------------------------- (Principal Financial October 28, 1999
Thomas R. Staab II and Accounting Officer)
*
- --------------------------- Director and President October 28, 1999
M. Nixon Ellis
*
- --------------------------- Director October 28, 1999
Anthony B. Evnin
*
- --------------------------- Director October 28, 1999
Standish M. Fleming
- --------------------------- Director October ___, 1999
Dennis B. Gillings
- --------------------------- Director October ___, 1999
Henry G. Grabowski
- --------------------------- Director October ___, 1999
Arthur J. Higgins
*
- --------------------------- Director October 28, 1999
George McFadden
*By: /s/ DAVID W. BARRY
- ---------------------------
David W. Barry
ATTORNEY-IN-FACT
